Metropolitan Medical Center is a private tertiary hospital located at G. Magsangkay Street in Santa Cruz, Manila. The hospital is based in a 27-storey medical tower, and is fully equipped with diagnostic equipment and a fully automated diagnostic laboratory. It is staffed by more than 300 doctors.

During the past decade, Metropolitan Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metropolitan Medical Center" #1 sponsor was "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials, followed by "Ipsen" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Corbridge Group Philippines, Inc." with 1 trials sponsored and "Novartis" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metropolitan Medical Center" #1 collaborator was "Alfasigma S.p.A." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Metropolitan Medical Center" are "Cervical Dystonia" (1 trials), "Chronic Kidney Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Epilepsy, Partial Seizures" (1 trials) and "Epilepsy, Primary Generalized Tonic-Clonic Seizures" (1 trials). Many other conditions were trialed in "Metropolitan Medical Center" in a lesser frequency.

Most popular intervention types in "Metropolitan Medical Center" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Pregabalin Dose Level 1" (2 trials), "Pregabalin Dose Level 2" (2 trials), "Amlodipine + Olmesartan medoxomil" (1 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Metropolitan Medical Center" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Metropolitan Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Metropolitan Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Metropolitan Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".